News from Li Lab

Unraveling the mechanisms behind NSV

This study published in Nature Medicine, 2023 provides a comprehensive evaluation of the viral, cellular and immune mediators of a subset of individuals with persistent low-level viremia 

SARS-CoV-2 Virologic Rebound with Paxlovid

This observational study published in Annals of Internal Medicine, 2023 estimated the effect of Nirmatrelvir-ritonavir use on the frequency and duration of Viral Rebound among persons with mild to mderate COVID-19.

ID Week 2023

Our paper studying the immunological and virological features of HIV post-treatment controllers was highlighted in “What’s Hot in HIV Basic Science Lecture” during ID Week 2023.

Congratulations to Trevor Tamura!

Trevor Tamura received a research excellence award for his poster presentation titled “Analysis of emerging drug resistance after nirmatrelvir-ritonavir treatment and during post-treatment virologic rebound” at Discover Brigham 2023.